Sectra Full Year 2025 Earnings: Misses Expectations

Sectra (STO:SECT B) Full Year 2025 Results

Key Financial Results

• Revenue: kr3.31b (up 9.2% from FY 2024).
• Net income: kr563.4m (up 32% from FY 2024).
• Profit margin: 17% (up from 14% in FY 2024). The increase in margin was driven by higher revenue.
• EPS: kr2.92 (up from kr2.22 in FY 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sectra Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 8.2%.

The primary driver behind last 12 months revenue was the Imaging IT Solutions segment contributing a total revenue of kr2.80b (84% of total revenue). Notably, cost of sales worth kr2.04b amounted to 62% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to kr665.3m (88% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of kr45.6m. Explore how SECT B's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Healthcare Services industry in Sweden.

Performance of the Swedish Healthcare Services industry.

The company's shares are up 2.3% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Sectra's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.